Showing results (271-280 of 334) with videos related to
Sort By:
Pageof 34
Journal of Hypertension|August 19, 2022
Impact of various night-time period definitions on nocturnal ambulatory blood pressureJanis M Nolde, Graham S Hillis, Emily Atkins, et al.Journal of Hypertension|June 19, 2025
Automated office blood pressure measurement: a Hypertension Australia and National Hypertension Taskforce of Australia position statementJames E Sharman, Aletta E Schutte, Mark R Nelson, et al.Journal of Hypertension|March 19, 2024
Ambulatory blood pressure after 12 weeks of quadruple combination of quarter doses of blood pressure medication vs. standard medicationJanis M Nolde, Emily Atkins, Simone Marschner, et al.JMIR Research Protocols|August 21, 2025
Development of the Double-Blind, Randomized Trials of Effects of Antihypertensive Medicines (DREAM) Database and Characteristics of the Included Trials: Protocol for an Umbrella Review and Meta-AnalysesAbdul Salam, Rupasvi Dhurjati, Kota Vidyasagar, et al.JAMA|May 28, 2026
Adverse Effects and Treatment Discontinuation of Blood Pressure-Lowering Drugs and Combinations: A Network Meta-AnalysisNelson Wang, Stephen Van Der Hoorn, Rashmi Pant, et al.BMJ Open|November 1, 2016
Text2PreventCVD: protocol for a systematic review and individual participant data meta-analysis of text message-based interventions for the prevention of cardiovascular diseasesClara K Chow, Sheikh Mohammed Shariful Islam, Andrew Farmer, et al.Journal of Affective Disorders|February 20, 2024
Cognitive outcomes from the randomised, active-controlled Ketamine for Adult Depression Study (KADS)Donel M Martin, Anna J Harvey, Bernard Baune, et al.Lancet (London, England)|August 30, 2025
Blood pressure-lowering efficacy of antihypertensive drugs and their combinations: a systematic review and meta-analysis of randomised, double-blind, placebo-controlled trialsNelson Wang, Abdul Salam, Rashmi Pant, et al.Open Heart|November 2, 2019
Mobile phone text-messaging interventions aimed to prevent cardiovascular diseases (Text2PreventCVD): systematic review and individual patient data meta-analysisSheikh Mohammed Shariful Islam, Andrew J Farmer, Kirsten Bobrow, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2005
Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer after moderately emetogenic chemotherapyDavid G Warr, Paul J Hesketh, Richard J Gralla, et al.Pageof 34